BIOshell A160 Peptide CN, 5 μm HPLC Column

5 μm particle size, L × I.D. 5 cm × 300 μm

Pricing and availability is not currently available.

Quality Level


stainless steel hardware (column)


suitable for USP L10


Shell thickness (0.6 μm)
Solid Core (3.5 μm)



analyte chemical class(es)


mfr. no.


extent of labeling

1.5% carbon loading


600 bar max. pressure
90 °C max. temp.


HPLC: suitable

L × I.D.

5 cm × 300 μm

surface coverage

2.2 μmol/m2


spherical silica particle platform

matrix active group

cyano phase

particle size

5 μm

pore size

160 Å

surface area

60 m2/g

operating pH range

1 - 8

separation technique

reversed phase

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

BIOshell 160 Å Peptide CN columns provide an alternative selectivity to the traditional C18 bonded phases. The introduction of the cyano group enables peptides and small proteins to be separated due to a combination of hydrophobicity and dipole-dipole interactions making this column an excellent choice for biomolecules that are not resolved on traditional C18 columns. These columns contain advanced Fused-Core particles with pores strategically sized to 160 Å to enable optimized peptide diffusion. This attribute makes these columns an excellent choice for peptide mapping. Additionally, the sterically-protected cyanopropyl ligands provide extra stability allowing the columns to be used at an extended pH range (2-9) and high temperatures (up to 90 °C).

Recommended products

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Legal Information

BIOshell is a trademark of Sigma-Aldrich Co. LLC

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.